June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Apr 26, 2024, 10:07

Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer

Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter:

HOT OFF THE PRESS.

BIG NEWS.

U.S. FDA approves adjuvant Alectinib following surgery in patients with stage IB-IIIA ALK+ Non-Small Cell Lung Cancer based on results of Alina trial:

High DFS HR: 0.24 (compared with adjuvant chemotherapy).”

Read further.
Source: Rami Manochakian/X